BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10654453)

  • 1. Absolute number of circulating CD34+ cells is abnormally low in refractory anemias and extremely high in RAEB and RAEB-t; novel pathologic features of myelodysplastic syndromes identified by highly sensitive flow cytometry.
    Fuchigami K; Mori H; Matsuo T; Iwanaga M; Nagai K; Kuriyama K; Tomonaga M
    Leuk Res; 2000 Feb; 24(2):163-74. PubMed ID: 10654453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome].
    Zhang Z; Xie J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
    Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
    Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia.
    Otawa M; Kawanishi Y; Iwase O; Shoji N; Miyazawa K; Ohyashiki K
    Leuk Res; 2000 Apr; 24(4):359-66. PubMed ID: 10713334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric evaluation of circulating CD34+ cell counts and apoptotic rate in children with acquired aplastic anemia and myelodysplasia.
    Timeus F; Crescenzio N; Doria A; Foglia L; Linari A; Giaccone M; Pastore G; di Montezemolo LC; Ramenghi U; Saracco P
    Exp Hematol; 2005 May; 33(5):597-604. PubMed ID: 15850838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
    Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
    Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes.
    Baur AS; Meugé-Moraw C; Schmidt PM; Parlier V; Jotterand M; Delacrétaz F
    Eur J Haematol; 2000 Feb; 64(2):71-9. PubMed ID: 10997326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Four-color flow cytometric immunophenotypic features of blasts in myelodysplastic syndromes].
    Wu YJ; Li JY; Qiu HR; Xiao B; Zhang JF; Song JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):50-3. PubMed ID: 16584591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent expansion of CD34+ cells during the evolution of myelodysplastic syndromes to acute myeloid leukemia.
    Span LF; Dar SE; Shetty V; Mundle SD; Broady-Robinson L; Alvi S; Raymakers RA; de Witte T; Raza A
    Leukemia; 1998 Nov; 12(11):1685-95. PubMed ID: 9823942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS.
    Parker JE; Mufti GJ; Rasool F; Mijovic A; Devereux S; Pagliuca A
    Blood; 2000 Dec; 96(12):3932-8. PubMed ID: 11090080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome.
    Sato T; Kim S; Selleri C; Young NS; Maciejewski JP
    Leukemia; 1998 Aug; 12(8):1187-94. PubMed ID: 9697872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
    Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
    Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotypic clustering of myelodysplastic syndromes.
    Maynadié M; Picard F; Husson B; Chatelain B; Cornet Y; Le Roux G; Campos L; Dromelet A; Lepelley P; Jouault H; Imbert M; Rosenwadj M; Vergé V; Bissières P; Raphaël M; Béné MC; Feuillard J;
    Blood; 2002 Oct; 100(7):2349-56. PubMed ID: 12239142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
    Wei J; Zhou XF; Zhao F; Zhou JF; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):111-6. PubMed ID: 19236759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes.
    Kalina U; Hofmann WK; Koschmieder S; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
    Exp Hematol; 2000 Oct; 28(10):1158-63. PubMed ID: 11027834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric analysis of Thy-1 expression in myelodysplastic syndrome.
    Inaba T; Shimazaki C; Sumikuma T; Shimura K; Takahashi R; Hirai H; Ashihara E; Sudo Y; Murakami S; Haruyama H; Fujita N; Yoshimura M; Nakagawa M
    Int J Hematol; 1998 Dec; 68(4):403-10. PubMed ID: 9885439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes.
    Gyger M; Infante-Rivard C; D'Angelo G; Forest L; Lussier P
    Am J Hematol; 1988 May; 28(1):13-20. PubMed ID: 3369432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.
    Shimazaki K; Ohshima K; Suzumiya J; Kawasaki C; Kikuchi M
    Br J Haematol; 2000 Sep; 110(3):584-90. PubMed ID: 10997968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia.
    Oliveira AF; Tansini A; Vidal DO; Lopes LF; Metze K; Lorand-Metze I
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27748021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.